Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Screening criteria: the need to deal with new developments and ethical issues in newborn metabolic screening.

Forman J, Coyle F, Levy-Fisch J, Roberts P, Terry S, Legge M.

J Community Genet. 2013 Jan;4(1):59-67. doi: 10.1007/s12687-012-0118-9.

3.

Risk management frameworks for human health and environmental risks.

Jardine C, Hrudey S, Shortreed J, Craig L, Krewski D, Furgal C, McColl S.

J Toxicol Environ Health B Crit Rev. 2003 Nov-Dec;6(6):569-720. Review.

PMID:
14698953
4.

Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.

Flynn MA, McNeil DA, Maloff B, Mutasingwa D, Wu M, Ford C, Tough SC.

Obes Rev. 2006 Feb;7 Suppl 1:7-66. Review.

PMID:
16371076
5.

Newborn screening conditions: What we know, what we do not know, and how we will know it.

Levy HL.

Genet Med. 2010 Dec;12(12 Suppl):S213-4. doi: 10.1097/GIM.0b013e3181fe5d77.

PMID:
21150366
6.

[The origin of informed consent].

Mallardi V.

Acta Otorhinolaryngol Ital. 2005 Oct;25(5):312-27. Italian.

PMID:
16602332
8.

Ethical, legal and social issues in newborn screening in the United States.

Therrell BL Jr.

Southeast Asian J Trop Med Public Health. 2003;34 Suppl 3:52-8.

PMID:
15906695
9.

An overview of newborn screening.

Levy PA.

J Dev Behav Pediatr. 2010 Sep;31(7):622-31. doi: 10.1097/DBP.0b013e3181eedf01. Review.

PMID:
20814260
10.

Expert consensus (SBC/SBHCI) on the use of drug-eluting stents: recommendations of the Brazilian society of interventional cardiology/ Brazilian society of cardiology for the Brazilian public single healthcare system.

Lima VC, Mattos LA, Caramori PR, Perin MA, Mangione JA, Machado BM, Coelho WM, Bueno RR.

Arq Bras Cardiol. 2006 Oct;87(4):e162-7. Review. English, Portuguese.

11.

Newborn screening for lysosomal diseases: current status and potential interface with population medical genetics in Latin America.

Giugliani R.

J Inherit Metab Dis. 2012 Sep;35(5):871-7. doi: 10.1007/s10545-011-9436-z.

PMID:
22231381
12.

Umbilical cord blood banking: implications for perinatal care providers.

Armson BA; Maternal/Fetal Medicine Committee, Society of Obstetricians and Gynaecologists of Canada..

J Obstet Gynaecol Can. 2005 Mar;27(3):263-90. English, French. Erratum in: J Obstet Gynaecol Can. 2005 Jul;27(7):673.

PMID:
15943003
13.

Conflicts of interest in research involving human beings.

Greco D, Diniz NM.

J Int Bioethique. 2008 Mar-Jun;19(1-2):143-54, 202-3. Review.

PMID:
18664007
14.

Newborn screening: an overview.

Carreiro-Lewandowski E.

Clin Lab Sci. 2002 Fall;15(4):229-38. Review.

PMID:
12776783
15.

[The wonderful history of neonatal screening].

Dhondt JL, Farriaux JP.

Ann Biol Clin (Paris). 2000 May-Jun;58(3):267-76. French.

16.

American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.

American Society of Clinical Oncology..

J Clin Oncol. 2003 Jun 15;21(12):2397-406.

PMID:
12692171
17.

Newborn screening: ethical, legal, and social implications.

Anderson R, Rothwell E, Botkin JR.

Annu Rev Nurs Res. 2011;29:113-32. Review.

PMID:
22891501
18.

Newborn screening in Pakistan - lessons from a hospital-based congenital hypothyroidism screening programme.

Afroze B, Humayun KN, Qadir M.

Ann Acad Med Singapore. 2008 Dec;37(12 Suppl):114-3.

19.

[Newborn screening as a predictive genetic test: principles and challenges].

Zschocke J.

Wien Med Wochenschr. 2012 Apr;162(7-8):168-75. doi: 10.1007/s10354-012-0062-7. German.

PMID:
22451084
20.

Revisiting the Wilson-Jungner criteria: how can supplemental criteria guide public health in the era of genetic screening?

Petros M.

Genet Med. 2012 Jan;14(1):129-34. doi: 10.1038/gim.0b013e31823331d0.

PMID:
22237442
Items per page

Supplemental Content

Support Center